ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,157Medicare Part D Prescriptions Filled, Including Refills

Rank: 98 out of 1006

$563K Total Retail Price of All Prescriptions

Rank: 179 out of 1006

341 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 341 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 341 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 8,852 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 433 416 1 1
AMLODIPINE BESYLATE 417 407 2 4
LISINOPRIL 394 362 3 3
WARFARIN SODIUM 374 374 4 8
LEVOTHYROXINE SODIUM 371 298 5 2
FUROSEMIDE 331 291 6 6
METOPROLOL TARTRATE 293 256 7 7
OMEPRAZOLE 263 227 8 9
DONEPEZIL HCL 245 244 9 17
PRAVASTATIN SODIUM 207 191 10 15
METOPROLOL SUCCINATE 182 170 11 12
MIRTAZAPINE 179 170 12 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 157 144 13 38
SERTRALINE HCL 155 155 14 19
CITALOPRAM HBR 154 153 15 24
GABAPENTIN 137 98 16 20
LANTUS 129 109 17 43
NAMENDA 129 129 17 34
CARVEDILOL 118 112 19 36
METFORMIN HCL 114 92 20 10
CLOPIDOGREL 111 106 21 46
ZOLPIDEM TARTRATE 110 88 22 14
RISPERIDONE 110 90 22 40
ESCITALOPRAM OXALATE 98 88 24 27
TAMSULOSIN HCL 97 79 25 23
DIOVAN 93 79 26 16
POTASSIUM CHLORIDE 91 83 27 30
ATORVASTATIN CALCIUM 89 79 28 5
GLIMEPIRIDE 82 46 29 50
PREDNISONE 80 68 30 33
ADVAIR DISKUS 80 50 30 37
ALENDRONATE SODIUM 79 77 32 29
HYDROCHLOROTHIAZIDE 74 74 33 11
PROAIR HFA 74 40 33 64
TRIAMTERENE-HCTZ 73 69 35 58
DIVALPROEX SODIUM 71 30 36 53
LEVETIRACETAM 70 67 37 72
ATENOLOL 68 68 38 13
LOSARTAN POTASSIUM 67 50 39 22
PLAVIX 62 62 40 61
CYMBALTA 61 29 41 41
CARBIDOPA-LEVODOPA 60 60 42 80
DIOVAN HCT 59 59 43 60
NOVOLOG 59 59 43 94
QUETIAPINE FUMARATE 59 52 43 45
JANUVIA 56 55 46 49
GLIPIZIDE 55 55 47 69
PANTOPRAZOLE SODIUM 54 46 48 32
PAROXETINE HCL 54 42 48 62
AZITHROMYCIN 53 46 50 39
DIGOXIN 52 46 51 52
LOVASTATIN 51 44 52 44
OXYCODONE-ACETAMINOPHEN 50 34 S2 53 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 31, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.